Literature DB >> 33546306

Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis.

Carmen de Jesús-Gil1, Lídia Sans-de San Nicolàs1, Ester Ruiz-Romeu1, Marta Ferran2, Laura Soria-Martínez1, Irene García-Jiménez1, Anca Chiriac3, Josep Manel Casanova-Seuma4, Josep Manel Fernández-Armenteros4, Sherry Owens5, Antonio Celada6, Michael D Howell5, Ramòn María Pujol2, Luis Francisco Santamaria-Babí1.   

Abstract

Candida albicans (CA) infections have been associated with psoriasis onset or disease flares. However, the integrated immune response against this fungus is still poorly characterized in psoriasis. We studied specific immunoglobulins in plasma and the CA response in cocultures of circulating memory CD45RA- cutaneous lymphocyte antigen (CLA)+/- T cell with autologous epidermal cells from plaque and guttate psoriasis patients (cohort 1, n = 52), and also healthy individuals (n = 17). A complete proteomic profile was also evaluated in plaque psoriasis patients (cohort 2, n = 114) regarding their anti-CA IgA levels. Increased anti-CA IgA and IgG levels are present in the plasma from plaque but not guttate psoriasis compared to healthy controls. CA cellular response is confined to CLA+ T cells and is primarily Th17. The levels of anti-CA IgA are directly associated with CLA+ Th17 response in plaque psoriasis. Proteomic analysis revealed distinct profiles in psoriasis patients with high anti-CA IgA. C-C motif chemokine ligand 18, chitinase-3-like protein 1 and azurocidin were significantly elevated in the plasma from plaque psoriasis patients with high anti-CA levels and severe disease. Our results indicate a mechanism by which Candida albicans exposure can trigger a clinically relevant IL-17 response in psoriasis. Assessing anti-CA IgA levels may be useful in order to evaluate chronic psoriasis patients.

Entities:  

Keywords:  CLA; Candida albicans; IL-17; IgA; psoriasis

Mesh:

Substances:

Year:  2021        PMID: 33546306      PMCID: PMC7913574          DOI: 10.3390/ijms22041519

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  55 in total

1.  Is the humoral immunity dispensable for the pathogenesis of psoriasis?

Authors:  J Thomas; M Küpper; R Batra; M Jargosch; A Atenhan; V Baghin; L Krause; F Lauffer; T Biedermann; F J Theis; K Eyerich; S Eyerich; N Garzorz-Stark
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-07-02       Impact factor: 6.166

Review 2.  Skin-homing T cells in human cutaneous allergic inflammation.

Authors:  L F Santamaria Babi; M T Perez Soler; C Hauser; K Blaser
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Fungal flora of human faeces in psoriasis and atopic dermatitis.

Authors:  M Buslau; I Menzel; H Holzmann
Journal:  Mycoses       Date:  1990-02       Impact factor: 4.377

4.  Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions.

Authors:  Luciana C Paulino; Chi-Hong Tseng; Bruce E Strober; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis.

Authors:  Dimitrios Nalmpantis; Asimina Gatou; Ioannis Fragkioudakis; Apostolia Margariti; Lemonia Skoura; Dimitra Sakellari
Journal:  J Periodontal Res       Date:  2019-10-14       Impact factor: 4.419

6.  Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis.

Authors:  Mehdi Taheri Sarvtin; Tahereh Shokohi; Zohreh Hajheydari; Jamshid Yazdani; Mohammad T Hedayati
Journal:  Int J Dermatol       Date:  2014-12       Impact factor: 2.736

Review 7.  IL-17 superfamily cytokines modulate normal germinal center B cell migration.

Authors:  Elisa Ferretti; Maurilio Ponzoni; Claudio Doglioni; Vito Pistoia
Journal:  J Leukoc Biol       Date:  2016-08-26       Impact factor: 4.962

Review 8.  Triggering psoriasis: the role of infections and medications.

Authors:  Lionel Fry; Barbara S Baker
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

9.  Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasis.

Authors:  B S Baker; A V Powles; A K Malkani; H Lewis; H Valdimarsson; L Fry
Journal:  Br J Dermatol       Date:  1991-07       Impact factor: 9.302

Review 10.  Psoriasis pathogenesis and the development of novel targeted immune therapies.

Authors:  Jason E Hawkes; Tom C Chan; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2017-09       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.